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Cannabidiol protects oligodendrocyte progenitor cells
from inflammation-induced apoptosis by attenuating
endoplasmic reticulum stress
M Mecha1, AS Torrao1,2, L Mestre1, FJ Carrillo-Salinas1, R Mechoulam3 and C Guaza*,1
Cannabidiol (CBD) is the most abundant cannabinoid in Cannabis sativa that has no psychoactive properties. CBD has been
approved to treat inflammation, pain and spasticity associated with multiple sclerosis (MS), of which demyelination and
oligodendrocyte loss are hallmarks. Thus, we investigated the protective effects of CBD against the damage to oligodendrocyte
progenitor cells (OPCs) mediated by the immune system. Doses of 1 lM CBD protect OPCs from oxidative stress by decreasing
the production of reactive oxygen species. CBD also protects OPCs from apoptosis induced by LPS/IFNc through the decrease
of caspase 3 induction via mechanisms that do not involve CB1, CB2, TRPV1 or PPARc receptors. Tunicamycin-induced OPC
death was attenuated by CBD, suggesting a role of endoplasmic reticulum (ER) stress in the mode of action of CBD. This
protection against ER stress-induced apoptosis was associated with reduced phosphorylation of eiF2a, one of the initiators of
the ER stress pathway. Indeed, CBD diminished the phosphorylation of PKR and eiF2a induced by LPS/IFNc. The pro-survival
effects of CBD in OPCs were accompanied by decreases in the expression of ER apoptotic effectors (CHOP, Bax and caspase
12), and increased expression of the anti-apoptotic Bcl-2. These findings suggest that attenuation of the ER stress pathway is
involved in the ‘oligoprotective’ effects of CBD during inflammation.
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Cannabidiol (CBD) is the most abundant cannabinoid in
Cannabis sativa that is devoid of psychoactive properties.
CBD exerts anti-inflammatory, antioxidant and neuroprotec-
tive effects,1 and it has been approved for the treatment of
inflammation, pain and spasticity associated with multiple
sclerosis (MS).2 Studies in an animal model of EAE have
shown that CBD ameliorates the severity of the disease by
attenuating neuroinflammation and axonal damage.3 Oligo-
dendrocyte progenitor cells (OPCs) are relatively quiescent
cells derived from precursors of the perinatal CNS that make
up around 5–8% of the glial cell population in the adult; in the
injured CNS, they can divide and are thought to differentiate to
new myelinating oligodendroytes that replace those that have
been lost in demyelinating areas.4 OPCs are highly vulnerable
to inflammation and oxidative stress as they have a high
metabolic rate, high intracellular iron, and low concentrations
of the antioxidative glutathione; they also express an arsenal
of molecules rendering them susceptible to inflammatory
cytokines or high calcium levels among others.5 It is known
that inflammation contributes to oligodendroglial damage in
demyelinating diseases such as MS.6 Synthetic cannabinoids
such asWIN 55212-2 and HU211 can protect oligodendrocyte
progenitors cells (OPCs) from the apoptosis induced by the
withdrawal of trophic support,7 although their utility is limited
due to their unwanted psychotropic effects. However, little is
known about the effects of CBD on the apoptosis of OPCs
induced by inflammation. Although CBD induces cytotoxicity
in oligodendrocytes of the optic nerve under basal conditions
by increasing intracellular calcium,8 it also prevents apoptotic
signaling in neurons by reducing calcium influx.9 The
pharmacological basis of the effects of CBD remains elusive,
although multiple potential targets of CBD have been
proposed in function of the stimuli and cell type involved.1
The endoplasmic reticulum (ER) stress response modu-
lates the response of oligodendrocytes to inflammatory
stimuli,10 and it involves the activation of the double-stranded
RNA-activated serine/threonine kinase (PKR), which has
been implicated as an important component of host
responses to infection and various situations of cellular
stress.11 PKR is one of the ER transmembrane protein factors
that coordinates an adaptive program known as the integrated
stress response by phosphorylating the translation initiation
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factor 2a (eIF2a).12 Oligodendrocytes produce vast amounts
of myelin and they are highly sensitive to homeostatic
changes in the ER.10 The most rapidly activated pathway in
conditions of ER stress involves translational repression,
which can be mediated by the activation of PKR among
others, and results in the phosphorylation of eiF2a.13 Although
this pathway appears to offer cytoprotection to a variety of cell
types,14 it can also activate apoptosis in others 15; particularly
in oligodendrocytes the ER stress outcome may be deter-
mined by the developmental status of the cell, as in fully
myelinated mature oligodendrocytes it promotes cell survival,
but in activelymyelinating/remyelinating oligodendrocytes leads
to cell death.10 Indeed, ER stress has been linked with the
apoptosis of myelinating oligodendrocytes induced by IFNg16
and during ischemia.17 Moreover, several human diseases that
involve demyelination/hypomyelination appear to involve aggra-
vated ER stress. In Charcot–Marie–Tooth disease,18 Vanishing
White Matter disease,19,20 and even in immune-mediated
demyelinating disorders such as MS,21 severe ER stress and
activation of the unfolded protein response (UPR) are con-
sidered central to the pathogenesis of the disease.
In the present study, we provide evidence that CBD offers
protection to OPCs against inflammation-induced damage, as
well as protecting OPCs from oxidative stress by decreasing
ROS production. Finally, we demonstrate that the protective
effects of CBD against inflammatory damage and ER stress
are associated with modifications in the expression of
apoptotic effectors of the UPR.
Results
Dose–response studies of the effects of CBD on OPCs.
As CBD has different effects on distinct cell types, we
evaluated its effects on primary OPC cultures under basal
conditions. In dose–response experiments (0.1, 1, 2.5 and
5mM) CBD failed to induce cell death at low concentrations (0.1
and 1mM: Figure 1a), although some cytotoxicity was observed
at higher concentrations, resulting in the death of 23.38±3.98%
of cells (Pp0.01) after a 24-h exposure to 2.5mM CBD, and of
33.13±5.6% (Pp0.001) at 5mM. Based on these findings, a
dose of 1mM was selected for the subsequent experiments.
We next investigated the effect of CBD (1mM) on the cell cycle
by evaluating OPC proliferation. Quantification of BrdUþ cells in
OPC primary cultures (n¼ 10000 cells, Figure 1b) revealed that
CBD did not increase the proliferation of OPCs in vitro
(47.65±8.61%) with respect to the controls (48.21±10.5%).
These resultswere confirmedby subsequently analyzing the cell
cycle by flow cytometry (Figure 1c), in which no differenceswere
observed between G0/G1, S and G2/M phases.
At doses of 0.1 and 1 mM, CBD has been reported to
increase intracellular Ca2þ and to induce oligodendrocyte
death in the optic nerve.8 Thus, we investigated whether 1 mM
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Figure 1 Effects of CBD on OPC cytotoxicity. (a) Although CBD did not induce cell death at low concentrations (0.1 and 1mM), cytotoxic effects were observed at 2.5 and
5mM. OPCs were exposed to CBD and cell death was quantified 48 h later using the LDH method. Data represent the mean±S.E.M. of n¼ 3 cultures analyzed in triplicate.
Statistical significance was determined by a one-way ANOVA: **Pp0.01 and ***Pp0.001 versus untreated cells. (b) CBD did not augment OPC proliferation evident as an
increase in BrdU incorporation. OPCs were incubated with BrdU (10 mM) for 24 h and at least 10 000 cells were then quantified by immunocytochemistry. (c) Flow cytometry
analysis revealed the CBD does not affect the cell cycle progression of OPCs. Freshly isolated OPCs were incubated for 24 h in the presence or absence of CBD (1 mM), and
the cell cycle of a minimum of 10 000 cells was analyzed on a FACSAria flow cytometer following PI staining. (d, e) CBD did not alter intracellular Ca2þ levels under basal
conditions. OPCs were loaded with the Ca2þ -sensitive dye Fluo-4 and the fluorescence signal was monitored on a scanning confocal microscope under basal conditions and
after adding CBD (1 mM: n¼ 5 coverslips). (d) Representative pseudocolor images showing Ca2þ levels in cultured OPCs under basal conditions and in the presence of CBD
(1mM). Scale bar¼ 50mm. (e) Fluorescence traces showing the Ca2þ time course in individual OPCs (n¼ 8) from the experiment shown in (d), both under basal conditions
and in the presence of CBD.
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CBD-induced Ca2þ release from intracellular stores in
cultured OPCs loaded with the Ca2þ -sensitive dye, Fluo-4.
There was no difference in the fluorescence signal obtained
under basal conditions and in the presence of CBD
(1mM: Figures 1d and e), indicating that intracellular Ca2þ
levels were not significantly modified by CBD.
CBD protects OPCs from inflammatory stimuli and from
apoptosis in a cannabinoid receptor-independent
manner. As we previously reported that the LPS/IFNg
inflammatory stimuli induced cytotoxicity in OPCs,22 it was
noteworthy that CBD (1mM) protected OPCs from the
noxious effects of inflammation (Pp0.001, Figure 2a),
decreasing cell death from 37.84±4.95% to 10.41±4.41%.
Indeed, the induction of the apoptotic effector caspase 3
(Figure 2b) by LPS/IFNg was reversed by the treatment with
CBD (Pp0.05), and the number of TUNELþ cells
(24.35±1.54%) fell to control levels in the presence of
CBD (3.34±0.96%, Pp0.001) when quantified 24 h post
treatment (Figures 2c and d). To investigate the mechanisms
underlying the oligoprotection offered by CBD, antagonists of
CB1, CB2, TRPV1 and PPARg receptors were administered
before the LPS/IFNg insult in the presence and absence of
CBD. None of these antagonists reversed the protective
effects of CBD observed in inflammatory conditions, sug-
gesting that the effects of CBD are not mediated by these
receptors (Figure 2a).
CBD rescues OPCs from H2O2-induced death by
decreasing ROS production. CBD is a resorcinol-based
compound with direct and potent antioxidant properties;23
hence, we investigated whether CBD acts as an antioxidant
in OPCs subjected to oxidative stress by evaluating its
effects on the cell death and ROS production induced by
hydrogen peroxide (100 mM). CBD prevented the detachment
and swelling of OPCs induced by direct oxidative stress
(Figure 3a), and decreased cell death from 84.89±6.93% to
39.12±1.82% (Pp0.01, Figure 3b). Moreover, this effect
was accompanied by a decrease in ROS production,
as determined in DCF-DA assays 1 h post treatment (H2O2þ
vehicle, 216.63±15.7%; H2O2þCBD, 151.59±5.10%:
Pp0.001, Figure 3c). To separate the antioxidant properties
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Figure 2 CBD protects against inflammatory damage by diminishing apoptosis and decreases the number of TUNELþ OPCs through a mechanism that does not involve
CB1, CB2, TRPV1 or PPARg receptors. (a) LPS/IFNg-induced cytotoxicity in OPCs was attenuated by CBD, a dose of 1 mM proving to be the most effective). Administration of
CB1, CB2, TRPV1 or PPARg antagonists (SR1, AM639, CPZ: 1 mM and GW9662: 50 nM) 30 min before the stimulus had no effect, indicating that none of these receptors are
implicated in the protective effects of CBD. The data represent the mean±S.E.M. of n¼ 3 independent cultures analyzed in triplicate, and the statistical analysis was
performed using Kruskal–Wallis ANOVA followed by Mann–Whitney U test: ***Pp0.001 versus untreated cells, #Pp0.05 and ###Pp0.001 versus cells exposed to LPS/IFNg
alone. (b) Cleaved caspase3 western blot shows that LPS/IFNg treatment induces the activation of the apoptotic pathway, whereas the co-treatment with CBD reduces this
induction. OPCs were incubated with LPS/IFNg in presence or absence of CBD (1mM). Total protein extracts were prepared 24 h later and cleaved caspase 3 (19 KDa) was
assessed in western blots probed with specific antibodies. The data represent the mean±S.E.M. optical density normalized to tubulin from three independent cultures
analyzed in triplicate, and statistical analysis was performed using one-way ANOVA followed by the Bonferroni post-hoc test: **Pp0.01 compared with non-treated cells,
#Pp0.05 compared with LPS/IFNg group. (c and d) A2B5 and TUNEL staining show that LPS/IFNg decreased OPC number by inducing apoptosis, an effect that was
reversed by CBD as previously confirmed by caspase 3 measurement. OPCs were exposed for 24 h to the cytotoxic stimulus, in the presence or absence of CBD (1mM), and
6000 OPCs cells were counted. Data represent the mean±S.E.M., and the statistical significance was determined using the Kruskal–Wallis ANOVA followed by Mann–
Whitney U test: ***Pp0.001 versus untreated cells, and ###Pp0.001 versus cells exposed to LPS/IFNg alone
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of CBD of its possible cytoprotective effects on OPCs during
inflammation, we also evaluated the effects of CBD on NO
production in response to LPS/IFN-g by measuring nitrites
and by western blot to assess NOS-2 expression, but CBD
was not able to modify NO production (data not shown).
ER stress induces OPC death, an effect that is
attenuated by CBD via decreased eiF2a phosphorylation.
As ER stress is implicated in several diseases with inflamma-
tory components, such as MS,21 we analyzed primary OPC
death in response to activation of this cellular program.
Tunicamycin-induced ER stress led to OPC death 24h post
treatment (45.81±4.7%: Figure 4a), which was attenuated
by treatment with CBD (20.39±2.54%, Pp0.01). Exposure to
CBD also decreased the phosphorylation of the eiF2a protein
(Pp0.05), an initiator of the apoptotic pathway induced by
ER stress (Figure 4b). Interestingly, tunicamycin-induced ER
stress was not mediated by the phosphorylation of PKR, a
potential activators of eiF2a in the ER (data not shown).
CBD attenuates the activation of the ER apoptotic
pathway in inflammatory conditions. Given the link
between the mechanisms underlying inflammation and ER
stress recently reported,24 we investigated the ER stress
response induced by LPS/IFNg. When we examined
the effect of LPS/IFN-g on PKR and eiF2a phosphorylation
in OPCs, an increase in the phosphorylation of these
proteins was evident in Western blots (Figures 4c and d).
Interestingly, CBD impaired this increase in PKR and
eiF2a phosphorylation, which remained at control levels
(Pp0.05), suggesting that one of the protective effects of
CBD in OPCs involves the reduction of ER stress during
neuroinflammation.
To confirm the effects of CBD in combating the ER stress
associated with inflammation, we analyzed ER mediators
of the apoptotic pathway. CBD significantly dampened the
induction of ER pro-apoptotic molecules by LPS/IFNg, such
as the initiator CHOP, a major ER stress marker, and the
effector caspase 12, as evident by real-time (RT)-PCR
(Pp0.01: Figure 5). In addition, the balance of pro-apoptotic
(Bax) and anti-apoptotic (Bcl-2) proteins, which is deregulated
by LPS/IFNg treatment, returned to the basal state in the
presence of CBD (Pp0.05). Furthermore, the expression of
GADD34, a negative feedback protein in this pathway
augmented when OPCs were treated with CBD (Pp0.001),
suggesting that this cannabinoid represses this apoptotic
program.
Discussion
In this study, we show that the nonpsychotropic cannabinoid,
CBD, prevents OPC death induced by inflammatory, oxidative
or direct ER stress. CBD does not modify the OPC cell cycle
and its protective effect was unaltered by classical cannabi-
noid, vanilloid or PPARg receptor antagonists. Moreover, the
anti-apoptotic effect of CBD appears to be mediated by
decreasing the expression of pro-apoptotic effectors and
dampening the activity of the ER stress pathway. These
findings define a novel mode of action for CBD in OPCs,
supporting its therapeutic potential to protect OPCs in
pathologies involving demyelination.
Neuroinflammation is one of the primary mechanisms
underlying the pathogenesis of MS, and proinflammatory
mediators are considered key effectors of the damage
in demyelinating disorders. Indeed, previous studies have
shown that inflammatory stimuli induce apoptosis in
OPCs.6,22 When we initially studied the effects of CBD on
primary OPC cultures, cytotoxic effects were only observed at
doses 42.5 mM. At doses of 0.1 and 1 mM, CBD was
previously reported to increase intracellular calcium and
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Figure 3 Oxidative stress induced by H2O2 induces OPC detachment and death, an effect that was attenuated by CBD by decreasing ROS production. (a) Phase contrast
images ( 10) show that treatment with H2O2 induced the swelling and detachment of OPCs, an effect prevented by CBD treatment. (b) CBD protects OPCs from oxidative
stress. OPCs were treated with H2O2 in the presence or absence of CBD (1 mM) and cell death was quantified 18 h later using the LDH method. The data represent the
mean±S.E.M. of four independent cultures analyzed in triplicate, and the statistical significance was determined using one-way ANOVA followed by the Bonferroni post-hoc
test: ***Pp0.001 versus untreated cells, ##Pp0.01 versus cells exposed to H2O2 alone. (c) CBD decreased ROS production under conditions of oxidative stress. OPCs were
loaded with DCF-DA for 30 min and stimulated with H2O2 in the presence or absence of CBD (1 mM). Fluorescence was measured 2 h later at 485/530 nm in a microplate
reader and the data represent the means±S.E.M. of n¼ 3 independent cultures analyzed in triplicate. Statistical significance was determined using Kruskal–Wallis ANOVA
followed by Mann–Whitney U test: ***Pp0.001 versus untreated cells, ###Pp0.001 versus cells exposed to H2O2 alone
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provoke cytotoxic effects,8 although no such Ca2þ influx was
observed here on exposure to 1mM CBD. These conflicting
findings may reflect the different source of oligodendrocytes
(optic nerve versus encephalon) and/or the state of differ-
entiation of the cells (mature oligodendrocytes versus
progenitors), pointing out to a different effect of CBD
depending on the developmental state of the cell. Although
CBD has previously been implicated in the regulation of the
cell cycle,1 we ruled out this possibility by studying BrdU
incorporation and cell cycle progression. Importantly, at low
doses, CBD protected OPCs from LPS/IFNg-induced cell
death, evident by the reduction of caspase 3 and the number
of TUNELþ cells. Although CBD protected OPCs from
inflammatory damage, we did not observe alterations neither
in nitrites nor NOS-2 induction by LPS/IFN-g, indicating the
lack of participation of NO in the protective effects of CBD.
Although CB1 and CB2 receptors were expressed on OPCs,7
CBD-induced protection of OPCs was not mediated by the
activation of these receptors. Blocking of vanilloid receptors or
of the nuclear receptor PPARg also had no effect on the
capacity of CBD to protect OPCs from inflammatory damage,
precluding the involvement of these receptors. These findings
are consistent with reports of other effects of CBD that occur
independently of classical and alternative cannabinoid
receptors.25
CBD protected OPCs from hydrogen peroxide-induced
oxidative stress by diminishing ROS production, consistent
with the antioxidant properties attributed to this compound in
different experimental models.26 This is an important finding,
as OPCs are very vulnerable to oxidative stress,27 considered
to be one of the pathogenic mechanisms underlying
demyelination and axonal damage in MS.
Oligodendrocytes are very sensitive to alterations in ER
homeostasis. Misfolded proteins generate ER stress and
contribute to cell death in pathophysiological conditions, while
mutations affecting the folding of myelin constituents lead to
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Figure 4 OPC death is mediated by ER stress, an effect that is attenuated by CBD through decreased PKR and eiF2a phosphorylation in conditions of inflammation.
(a) CBD attenuated tunicamycin-induced OPC death. OPCs were incubated with tunicamycin (1mg/ml) in the presence or absence of CBD (1 mM), and cell death was
quantified 24 h later by the LDH method. The data represent the mean±S.E.M. of three independent cultures analyzed in triplicate, and the statistical significance was
determined using Kruskal–Wallis ANOVA followed by Mann–Whitney U test: ***Pp0.001 versus untreated cells, ##Pp0.01 versus cells exposed to tunicamycin alone.
(b) Tunicamycin treatment induced the eiF2a phosphorylation, an effect that was attenuated by CBD. OPCs were incubated with tunicamycin (1mg/ml) in the presence or
absence of CBD (1 mM). Total protein extracts were prepared 5 min later and the phosphorylated (38 kDa) and total (38 kDa) eiF2a was assessed in western blots probed with
specific antibodies. The data represent the mean±S.E.M. optical density normalized to tubulin from four independent cultures analyzed in triplicate, and the statistical
significance was determined using Kruskal–Wallis ANOVA followed by Mann–Whitney U test: **Pp0.01 versus untreated cells, #Pp0.05 versus cells exposed to tunicamycin
alone. (c and d) Inflammation-induced PKR and eiF2a phosphorylation, an effect that was attenuated by CBD. OPCs were treated with LPS/IFNg in the presence or absence
of CBD (1 mM). Total protein extracts were prepared 5 min later and PKR (phosphorylated, 68 kDa; total, 68 kDa) and eiF2a (phosphorylated, 38 kDa; total, 38 kDa)
was assessed in western blots probed with specific antibodies. The data represent the mean±S.E.M. optical density normalized to tubulin from five cultures, and the
statistical significance was determined using Kruskal–Wallis ANOVA followed by Mann–Whitney U test: **Pp0.01 versus untreated cells, #Pp0.05 versus cells exposed to
LPS/IFNg alone
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oligodendrocyte death.28 We investigated the role of ER
stress in OPC death in vitro. Tunicamycin, an ER stressor,
induced OPC cytotoxicity through a mechanism that involved
the phosphorylation of eiF2a, without altering PKR phospho-
rylation, suggesting that the induction of the UPR pathway
with the tunicamycin treatment can be mediated by other ER
transmembrane protein factors such as IRE1a or ATF6.
Activating this pathway has been linked with the develop-
mental status of the cell 10 and here we present evidence of
the detrimental effects of ER stress in OPCs. The ability of
CBD to protect OPCs from the damage caused by ER stress
through decreasing eiF2a phosphorylation highlights
the potential therapeutic properties of this compound in
pathological conditions in which ER homeostasis is compro-
mised, as proposed in neurodegenerative and demyelinating
diseases.29,30
There is substantial evidence linking inflammation with ER
stress through several intracellular pathways.11,24 In animal
models of MS, IFNg induces ER stress in actively myelinating
oligodendrocytes, leading to apoptosis and abnormalities in
neuronal myelination.31 Our results point to the crosstalk
between inflammation and ER stress in OPCs, as LPS/IFNg-
induced cell death involved the phosphorylation of PKR
and eiF2a and hence, the apoptotic pathway activated
by the UPR. This pathway has been associated with increased
expression of pro-apoptotic factors, such as the CHOP
transcription factor (C/EBP homologous protein)32 that primarily
promote apoptosis by repressing Bcl-2 expression33 or by
inducing caspase 12.34 In OPCs, we found that inflammation
involved caspase 3 activation, induced the expression of CHOP
and caspase 12, and altered the balance between Bax and
Bcl-2, implicating ER stress in cell apoptosis.
Our findings constitute the first evidence that CBD protects
OPCs from inflammation-induced apoptosis by blocking ER
stress. In inflammatory conditions, CBD decreased the levels
of phosphorylated PKR and eiF2a in OPCs. Moreover,
this effect was accompanied by the restoration of CHOP,
caspase 12, Bcl-2 and Bax mRNA to control levels, together
with an increase in GADD34 expression, a negative feedback
regulator of this pathway.35
In summary, the findings presented here indicate that low
doses of CBD exert oligoprotective effects in OPCs under
conditions of inflammation, oxidative and ER stress. In
conditions of oxidative stress, the protective effect of CBD
was mediated by a decrease in ROS production, while under
neuroinflammatory conditions, CBD combated apoptosis
by decreasing ER stress through the modulation of the
PKR-eiF2a pathway. We propose that CBD, a C. sativa
derivative that lacks psychoactive properties, is a good
candidate to protect OPCs from different cytotoxic insults,
with significant therapeutic potential for the treatment of
demyelinating pathologies.
Material and Methods
Animals. Animal handling and care was performed in compliance with European
Union guidelines (86/609/EEC) and Spanish regulations (BOE67/8509-12; BOE1201/
2005) regarding the use and care of laboratory animals, and all the protocols were
approved by the local Animal Care and Ethics Committee of the CSIC.
Reagents. Griess reagent (sulfanilamide, N-(1-naphtyl)ethylenediamine), BrdU,
DCFDA, hydrogen peroxide, LPS and tunicamycin were purchased from Sigma-
Aldrich (Madrid, Spain). IFNg was acquired from Peprotech (London, UK), CPZ
from Alexis Biochemicals (Lausen, Sweden), CBD, AM630 and GW9662 from
Tocris (Bristol, UK) and SR1 was kindly provided by Sanofi-Aventis (Montpellier,
France).
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Figure 5 Inflammation activates the ER apoptotic pathway in OPCs, an effect that was attenuated by CBD. (a) CBD attenuated the inflammation-induced increase in
CHOP expression. (b) The upregulation of caspase 12 expression in conditions of inflammation was attenuated by CBD. (c) CBD restores the Bcl-2/Bax balance in OPCs
treated with LPS/IFNg. (d) CBD increases the expression of the negative feedback regulator GADD34 under conditions of inflammation. In all cases, OPCs were incubated
with LPS/IFNg in the presence or absence of CBD (1mM). The mRNA expression of each gene was measured 24 h later by quantitative RT-PCR and normalized to the
expression of the 18S gene. The data represent the mean±S.E.M. of three independent cultures analyzed in triplicate, and the statistical significance was determined using
Kruskal–Wallis ANOVA followed by Mann–Whitney U test: *Po0.05, ***Pp0.001 versus untreated cells; and #Pp0.05, ##Pp0.01 versus cells exposed to LPS/IFNg alone
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Culture of oligodendrocyte progenitors. Primary cultures of OPCs
derived from P0–P2 Wistar rats were prepared as described previously,22,36 with
some modifications in doi:10.1038/protex.2011.218 (Open Nature exchange
protocols only on line). Cells were plated on poly-D-lysine-coated plates at 50 000
cells/cm2 for western blotting or 25 000 cells/cm2 for other assays, and they were
maintained for 3 days at 37 1C and 5% CO2 in serum-free defined medium
containing 5 ng/ml of growth factors (bFGF and PDGF-AA).
Cell toxicity. Oligodendrocyte death was quantified by measuring the release
of lactate dehydrogenase (LDH) from damaged cells into the bathing medium 18,
24 and 48 h after exposure to hydrogen peroxide, tunicamycin and LPS/IFNg,
respectively, according to the manufacturer’s instructions (cytotoxicity detection kit,
Roche, Manhein, Germany). All experiments compared the cell death induced with
the basal levels of cell death in the cultures.
TUNEL assay. OPCs were seeded on poly-D-lysine-coated coverslips and
maintained for 24 h with LPS/IFNg and/or CBD. After they were fixed in 4% PFA,
post-fixed in EtOH/acetic acid for 5 min at  20 1C and maintained in equilibration
buffer for 1 min, they were incubated with the TdT enzyme in a reaction buffer for
1 h at 37 1C (Apoptosis detection kit, Chemicon, Millipore Ibe´rica, Madrid, Spain).
After washing, the coverslips were incubated with the anti-DIG antibody in blocking
solution and counterstained with DAPI. The data represent TUNELþ cells as a
percentage of the total number of cells.
Immunocytochemistry. For BrdU analysis, OPCs were seeded on poly-D-
lysine-coated coverslips and incubated with BrdU (10 mM) for 24 h in the presence
or absence of CBD. Cells were then fixed in 4% PFA for 20 min, treated with 2 N
HCl for 10 min, blocked and incubated with anti-BrdU antibody (DSHB, 1:1000).
After washing, the cells were incubated with an anti-mouse secondary antibody
(1:1000) and counterstained with DAPI. For A2B5 staining, the cells were treated
for 24 h with LPS/IFNg in the presence or absence of CBD, incubated in vivo with
anti-A2B5 marker (R&D Systems, Mineapolis, MN, USA, 1:200), fixed in 4% PFA
and incubated with the secondary antibody (1:1000).
Flow cytometry. Freshly isolated OPCs were maintained on uncoated plates for
24 h with vehicle or CBD. The cells were then collected, fixed in cold 70% ethanol for
30 min, resuspended in phosphate buffer saline (PBS) and incubated with 100mg/ml
Ribonuclease A (Sigma-Aldrich) and 50mg/ml propidium iodide (PI; Sigma-Aldrich) for
30 min. Argon laser excitation at 488 nm was used to measure PI fluorescence
through a band-pass 616/23 nm filter using a FACSAria flow cytometer (BD
Biosciences, San Diego, CA, USA). Debris and duplets were excluded from the
analysis and a minimum of 10 000 cells were acquired in each experiment. FACSDiva
analysis software (BD Biosciences) was used to define the cell cycle stages.
Measurement of intracellular Ca2þ . Cells were seeded on coverslips
and incubated for 20–30 min at 37 1C in PBS containing Fluo4-AM (0.3mM,
Invitrogen, Barcelona, Spain) and pluronic F-127 (0.04%, Sigma-Aldrich). The
coverslips were then transferred to the microscope chamber and bathed in an
extracellular medium containing (in mM): NaCl 140, KCl 5, MgCl2 4, HEPES 10,
glucose 10 and sucrose 6 (pH 7.35). All experiments were performed at room
temperature. Cells were imaged with an Olympus (Barcelona, Spain) FV3 scanning
confocal microscope equipped with a  40 objective (NA, 0.8) and laser emission at
488 nm was used to excite Fluo-4. The fluorescent signal recorded is displayed as a
pseudocolor image and the look-up-table used is indicated in each figure. The time
frame acquisition was 1.12 s.
ROS determination. OPCs were loaded with dichlorodihydrofluorescein
diacetate acetyl ester (DCFDA, 2 mM) for 30 min, washed and stimulated with
hydrogen peroxide for 2 h or with LPS/IFNg for 24 h in the presence or absence of
CBD. Fluorescence was measured at 485/530 nm in a microplate reader and
normalized to the negative control.
Western blot analysis. Western blot analysis was performed as previously
described 7 using 30–40mg of OPC protein extract and an anti-cleaved caspase3
(Asp175; 1:1000, Cell Signaling Technology, Denvers, MA, USA), anti-phospho
(Ser51) eIF2a (1:1000; Cell Signaling Technology), anti-total eIF2a (1:1000; Cell
Signaling Technology), anti-phospho (Thr446) PKR (1:1000, Upstate, Millipore
Ibe´rica, Madrid, Spain) and anti-total PKR (1:1000, Millipore, Madrid, Spain). Anti-
a-tubulin (1:40 000; Sigma-Aldrich) was used as a loading control.
RNA extraction, reverse transcription and RT-PCR. Total OPC
RNA was extracted using the RNeasy mini columns kit (Qiagen, Crawley, UK) and
treated with DNaseI (Qiagen), and the RNA concentration and purity were
determined in a Nanodrop spectrophotometer (Nanodrop Technologies,
Wilmington, DE, USA). Total RNA (1mg) was reverse transcribed using the
Promega reverse transcription kit (Promega, Madrid, Spain) and RT-PCR was
performed on 1ml of cDNA (corresponding to 50 ng RNA input) with 200 nM of the
primers listed below (Applied Biosystems, Warrington, UK), quantifying expression
using SYBR Green (Applied Biosystems). The amplification cycles involved an
initial activation step at 50 1C for 2 min and a denaturation step at 95 1C for 10 min,
followed by 40 cycles of denaturation at 95 1C for 15 s and annealing/extension at
60 1C for 1 min. PCR assays were carried out in 96-well plates using a 7500 Real-
Time PCR system (Applied Biosystems). Each sample was assayed in duplicate
and a 6-point standard curve was run in parallel. The ratio between the values
obtained for each gene and the 18S house-keeping gene provided a relative
quantification of expression. The 50-30primer secuences used were the following:
CHOP (forward 50-CCAAAATAACAGCCGGAACCT-30; reverse 50-CAAAGGCG
AAAGGCAGAGACT-30), GADD34 (forward 50-AGCATGGACACGCCTTAGA
AA-30; reverse 50-AGGCTGGGAGGAGGGATTT-30), Bax (forward 50-GGGT
GGCAGCTGACATGTTT-30; reverse 50-TGATCAGCTCGGGCACTTTA-30), Bcl-2
(forward 50-TGAGAGCAACCGAACGCCCG-30; reverse 50-CCGTGGCAAAG
CGTCCCCTC-30), caspase 12 (forward 50-GAAGGAAGGCCGAACCCGCC-30;
reverse 50-TGCTCTGGACGGCCAGCAAAC-30) and 18S (forward 50-ATGCTCTT
AGCTGAGTGTCCCG-30; reverse 50-ATTCCTAGCTGCGGTATCCAGG-30)
Data analysis. All data are expressed as the mean±S.E.M. (n), where
n refers to the number of cultures assayed, each obtained from a different group of
animals and evaluated in triplicate. One-way ANOVA followed by the Bonferroni
post-hoc test, or Kruskal—Wallis ANOVA followed by Mann–Whitney U test was
used to determine the statistical significance in all cases. The level of significance
was set at Po0.05.
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